|
1
|
Weiss SW and Goldblum JR:
LiposarcomaEnzinger and Weiss's Soft Tissue Tumors. 5th. Weiss SW
Enzinger and Goldblum JR: Mosby Inc.; St. Louis: pp. 477–516.
2008
|
|
2
|
Dei Tos AP and Pedeutour F: Atypical
lipomatous tumorWHO Classification of Tumours of Soft Tissue and
Bone. Fletcher CDM, Bridge JA, Hogendoorn PCW and Mertens F: IARC;
Lyon: pp. 33–43. 2013
|
|
3
|
Coindre JM, Pédeutour F and Aurias A:
Well-differentiated and dedifferentiated liposarcomas. Virchows
Arch. 456:167–179. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Antonescu CR and Ladanyi M: Myxoid
liposarcomaWHO Classification of Tumours of Soft Tissue and Bone.
Fletcher CDM, Bridge JA, Hogendoorn PCW and Mertens F: IARC; Lyon:
pp. 39–41. 2013
|
|
5
|
Antonescu CR, Tschernyavsky SJ, Decuseara
R, Leung DH, Woodruff JM, Brennan MF, Bridge JA, Neff JR, Goldblum
JR and Ladanyi M: Prognostic impact of P53 status, TLS-CHOP fusion
transcript structure, and histological grade in myxoid liposarcoma:
A molecular and clinicopathologic study of 82 cases. Clin Cancer
Res. 7:3977–3987. 2001.PubMed/NCBI
|
|
6
|
Hosaka T, Nakashima Y, Kusuzaki K, Murata
H, Nakayama T, Nakamata T, Aoyama T, Okamoto T, Nishijo K, Araki N,
et al: A novel type of EWS-CHOP fusion gene in two cases of myxoid
liposarcoma. J Mol Diagn. 4:164–171. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Idbaih A, Coindre JM, Derré J, Mariani O,
Terrier P, Ranchère D, Mairal A and Aurias A: Myxoid malignant
fibrous histiocytoma and pleomorphic liposarcoma share very similar
genomic imbalances. Lab Invest. 85:176–181. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Siebert JD, Williams RP and Pulitzer DR:
Myxoid liposarcoma with cartilaginous differentiation. Mod Pathol.
9:249–252. 1996.PubMed/NCBI
|
|
9
|
Dijkhuizen T, Molenaar WM, Hoekstra HJ,
Wiersema J and van den Berg E: Cytogenetic analysis of a case of
myxoid liposarcoma with cartilaginous differentiation. Cancer Genet
Cytogenet. 92:141–143. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Wei YC, Li CF, Eng HL, Yeh MC, Lin CN and
Huang HY: Myxoid liposarcoma with cartilaginous differentiation:
Identification of the same type II TLS-CHOP fusion gene transcript
in both lipogenic and chondroid components. Appl Immunohistochem
Mol Morphol. 15:477–480. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Kim H, Hwangbo W, Ahn S, Kim S, Kim I and
Kim CH: Myxoid liposarcoma with cartilaginous differentiation: A
case study with cytogenetical analysis. Korean J Pathol.
47:284–288. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Ioannou MG, Kouvaras E, Papamichali R,
Karachalios T and Koukoulis G: Myxoid liposarcoma with
cartilaginous differentiation: A case study with fish analysis and
review of the literature. Pathol Res Pract. 209:666–669. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Nishio J, Althof PA, Bailey JM, Zhou M,
Neff JR, Barr FG, Parham DM, Teot L, Qualman SJ and Bridge JA: Use
of a novel FISH assay on paraffin-embedded tissues as an adjunct to
diagnosis of alveolar rhabdomyosarcoma. Lab Invest. 86:547–556.
2006.PubMed/NCBI
|
|
14
|
Simons A, Shaffer LG and Hastings RJ:
Cytogenetic nomenclature: Changes in the ISCN 2013 compared to the
2009 edition. Cytogenet Genome Res. 141:1–6. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Yamaguchi U, Hasegawa T, Morimoto Y,
Tateishi U, Endo M, Nakatani F, Kawai A, Chuman H, Beppu Y, Endo M,
et al: A practical approach to the clinical diagnosis of Ewing's
sarcoma/primitive neuroectodermal tumor and other small round cell
tumors sharing EWS rearrangement using new fluorescence in situ
hybridization probes for EWSR1 on formalin fixed, paraffin wax
embedded tissue. J Clin Pathol. 58:1051–1056. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Nishida Y, Tsukushi S, Nakashima H and
Ishiguro N: Clinicopathologic prognostic factors of pure myxoid
liposarcoma of the extremities and trunk wall. Clin Orthop Relat
Res. 468:3041–3046. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Fiore M, Grosso F, Lo Vullo S,
Pennacchioli E, Stacchiotti S, Ferrari A, Collini P, Lozza L,
Mariani L, Casali PG and Gronchi A: Myxoid/round cell and
pleomorphic liposarcomas: Prognostic factors and survival in a
series of patients treated at a single institution. Cancer.
109:2522–2531. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Tateishi U, Hasegawa T, Beppu Y, Kawai A
and Moriyama N: Prognostic significance of grading (MIB-1 system)
in patients with myxoid liposarcoma. J Clin Pathol. 56:579–582.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Enzinger FM and Shiraki M: Extraskeletal
myxoid chondrosarcoma. An analysis of 34 cases. Hum Pathol.
3:421–435. 1972. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Weiss SW and Goldblum JR: Malignant
mesenchymomaEnzinger and Weiss's Soft tissue tumors. 5th. Weiss SW
Enzinger and Goldblum JR: Mosby Inc.; St. Louis: pp. 1213–1214.
2008
|
|
21
|
Riggi N, Cironi L, Provero P, Suvà ML,
Stehle JC, Baumer K, Guillou L and Stamenkovic I: Expression of the
FUS-CHOP fusion protein in primary mesenchymal progenitor cells
gives rise to a model of myxoid liposarcoma. Cancer Res.
66:7016–7023. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Rodriguez R, Rubio R, Gutierrez-Aranda I,
Melen GJ, Elosua C, García-Castro J and Menendez P: FUS-CHOP fusion
protein expression coupled to p53 deficiency induces liposarcoma in
mouse but not in human adipose-derived mesenchymal stem/stromal
cells. Stem Cells. 29:179–192. 2011. View
Article : Google Scholar : PubMed/NCBI
|
|
23
|
Suzuki K, Matsui Y, Higashimoto M,
Kawaguchi Y, Seki S, Motomura H, Hori T, Yahara Y, Kanamori M and
Kimura T: Myxoid liposarcoma-associated EWSR1-DDIT3 selectively
represses osteoblastic and chondrocytic transcription in
multipotent mesenchymal cells. PLoS One. 7:e366822012. View Article : Google Scholar : PubMed/NCBI
|
